PNEUMOCOCCAL VACCINATION WITH 13-VALENT POLYSACCHARIDE CONJUGATE VACCINE FOR OLDER ADULTS WITH CHRONIC CONDITIONS: BUDGET IMPACT ANALYSIS IN COLOMBIA

被引：0
|
作者：
LaRotta, J. [1 ]
Sanchez, Reyes J. M. [2 ]
Gamboa, Castano N. [1 ]
机构：
[1] Pfizer SAS, Bogota, Colombia
[2] Pfizer SAS, Bogota, Cun, Colombia
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC103
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [31] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
    Olarte, Liset
    Barson, William J.
    Barson, Ryan M.
    Lin, Philana Ling
    Romero, Jose R.
    Tan, Tina Q.
    Givner, Laurence B.
    Bradley, John S.
    Hoffman, Jill A.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) : 767 - 775
  • [32] Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children
    Chapoutot, A. G.
    Dessein, R.
    Guilluy, O.
    Lagree, M.
    Wallet, F.
    Varon, E.
    Martinot, A.
    Dubos, F.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (03): : 607 - 611
  • [33] A cost-effectiveness analysis of vaccinating older adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to no vaccination, the 13-valent pneumococcal conjugate vaccine (PCV13), or PCV13 followed by PPV23 in Colombia
    Prieto, E.
    Jiang, Y.
    Yang, X.
    Graham, J. B.
    Monsanto, H.
    Ruiz, J.
    Beltran, C.
    Rojas, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 13 - 13
  • [34] Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
    Glesby, Marshall J.
    Watson, Wendy
    Brinson, Cynthia
    Greenberg, Richard N.
    Lalezari, Jacob P.
    Skiest, Daniel
    Sundaraiyer, Vani
    Natuk, Robert
    Gurtman, Alejandra
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (01): : 18 - 27
  • [35] Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in older adults
    Hsiao, Amber
    Lewis, Ned
    Hansen, John
    Timbol, Julius
    Suaya, Jose A.
    Alexander-Parrish, Ronika
    Grant, Lindsay R.
    Gessner, Bradford D.
    Klein, Nicola P.
    VACCINE, 2025, 44
  • [36] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Plosker, Greg L.
    DRUGS, 2015, 75 (13) : 1535 - 1546
  • [37] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Greg L. Plosker
    Drugs, 2015, 75 : 1535 - 1546
  • [38] Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis
    Vadlamudi, Nirma Khatri
    Chen, Anna
    Marra, Fawziah
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 34 - 49
  • [39] Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States
    McLaughlin, John M.
    Swerdlow, David L.
    Khan, Farid
    Will, Oliver
    Curry, Aaron
    Snow, Vincenza
    Isturiz, Raul E.
    Jodar, Luis
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 841 - 849
  • [40] An Open-label Trial to Assess the Safety of 13-Valent Pneumococcal Conjugate Vaccine in Older Adults, Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine.
    Schwarz, T. F.
    Pauksens, K.
    Juergens, C.
    Jayawardene, D.
    Emini, E. A.
    Gruber, W. C.
    Scott, D. A.
    Schmoele-Thoma, B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S30 - S30
12345